Louise Justesen Hesselbjerg

Summary

Publications

  1. doi request reprint Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide
    Louise Justesen Hesselbjerg
    Danish Center for Healthcare Improvements, Faculty of Social Sciences and Faculty of Health Sciences, Aalborg University, Denmark
    J Med Econ 16:845-58. 2013

Detail Information

Publications1

  1. doi request reprint Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide
    Louise Justesen Hesselbjerg
    Danish Center for Healthcare Improvements, Faculty of Social Sciences and Faculty of Health Sciences, Aalborg University, Denmark
    J Med Econ 16:845-58. 2013
    ..80; pā€‰=ā€‰0.003). The purpose is to review current economic evaluations of these alternatives for healthcare professionals to include these findings in their decision-making...